Amplicore Inc., an early-stage biopharmaceutical company currently developing locally delivered and minimally invasive therapeutic solutions for musculoskeletal diseases, has closed its Series Seed round of funding at $4 million. Investments were led by Photon Fund, with participation from Industrial Technology Investment Corporation, Berkeley Catalyst Fund, and SVE Capital. “We are very pleased to have accomplished […]
about people, work, and workplaces